MedTrace Logo

Evaluation of Contrast Enhanced Breast CT for Diagnosis and Staging of Breast Cancer

NCT05404087 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 413

Last updated 2022-06-03

No results posted yet for this study

Summary

Contrast-enhanced breast CT is a novel high resolution and fully 3D imaging method to document abnormalities within the breast. I will establish its value for breast cancer staging and in monitoring therapy response.

Conditions

Interventions

DEVICE

Dedicated breast CT

Administration of contrast agent and scanning of the breast in order to evaluate the enhancement of the tumor

Sponsors & Collaborators

  • The Netherlands Cancer Institute

    collaborator OTHER

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Ritse Mann, MD-PhD · Radboudumc/The Netherlands Cancer Institute

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2025-08-01
Completion
2025-08-01
FDA Device
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05404087 on ClinicalTrials.gov